RBC Antigen Profiles
Showing 1 - 25 of 6,311
Molecular Immunohematology in Ethiopian Sub-Populations
Suspended
- Immunohematology
-
Addis Ababa, EthiopiaAddis Ababa University
Feb 2, 2023
Primary Membranous Nephropathy Trial in Beijing (B007)
Not yet recruiting
- Primary Membranous Nephropathy
-
Beijing, ChinaPeking university first hospital
Dec 20, 2022
Triple Negative Breast Cancer Trial (Cryoablation, Cryoablation combined with PD1 Inhibitor)
Not yet recruiting
- Triple Negative Breast Cancer
- Cryoablation
- Cryoablation combined with PD1 Inhibitor
- (no location specified)
Mar 28, 2023
Will Permit Sites to Proactively Assess TAA, HLA and HPV-16
Terminated
- Head and Neck Cancer
- +7 more
- Tumor Profiling
-
Scottsdale, Arizona
- +2 more
Dec 2, 2022
Thrombotic Complications (CLOJAK)
Not yet recruiting
- Myeloproliferative Neoplasm
- Blood sampling
-
Angers, France
- +10 more
Apr 20, 2023
Sickle Cell Disease Trial in Atlanta (Biotin Labeled Red Blood Cells)
Recruiting
- Sickle Cell Disease
- Biotin Labeled Red Blood Cells
-
Atlanta, Georgia
- +2 more
Nov 1, 2021
Lymphoma Trial in Beijing (CD70-targeting CAR-T cells)
Recruiting
- Lymphoma
- CD70-targeting CAR-T cells
-
Beijing, Biotherapeutic Department Of Chinsese PLA Gereral Hospital, ChinaChina
Jul 9, 2023
Infant, Extremely Premature, Erythrocyte Transfusion, Umbilical Cord Issue Trial (Red blood cell from umbilical cord blood, Red
Not yet recruiting
- Infant, Extremely Premature
- +2 more
- Red blood cell from umbilical cord blood
- Red blood cell from adult donor
- (no location specified)
Nov 8, 2022
Red Blood Cell Transfusion, Anemia, and Necrotizing
Recruiting
- Necrotizing Enterocolitis
- +2 more
- RBC transfusion
- no-RBC transfusion
-
Chongqing, Chongqing, ChinaChildren's Hospital of Chongqing Medical University
Oct 13, 2022
Solid Tumor, Adult, EGFR Overexpression Trial in Beijing (TGFßR-KO CAR-EGFR T Cells)
Recruiting
- Solid Tumor, Adult
- EGFR Overexpression
- TGFβR-KO CAR-EGFR T Cells
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Mar 25, 2022
HER2 Positive Advanced Solid Tumors Trial (HypoSti.CAR-HER2 T cells, Albumin-bound paclitaxel, Cyclophosphamide)
Not yet recruiting
- HER2 Positive Advanced Solid Tumors
- HypoSti.CAR-HER2 T cells
- +2 more
- (no location specified)
Jan 12, 2023
Clinical Impact of Red Cell Storage Age
Recruiting
- RBC Transfusions
- no intervention
-
Minneapolis, MinnesotaUniversity of Minnesota
Aug 8, 2022
Sickle Cell Disease Trial in Atlanta (Etavopivat)
Not yet recruiting
- Sickle Cell Disease
-
Atlanta, GeorgiaEmory University Children's Healthcare of Atlanta
Feb 10, 2023
Hereditary Red Blood Cell Disorder (Disorder) Trial in Copenhagen, Utrecht (Mitapivat sulfate)
Not yet recruiting
- Hereditary Red Blood Cell Disorder (Disorder)
- Mitapivat sulfate
-
Copenhagen, Denmark
- +1 more
Jul 6, 2023
Prostate Cancer, Elevated Prostate Specific Antigen (PSA) Trial in Brooklyn, New York (serum specimens obtained will be utilized
Active, not recruiting
- Prostate Cancer
- Elevated Prostate Specific Antigen (PSA)
- serum specimens obtained will be utilized for proteomic profiling comprising MALDI-TOF MS, and serum biomarker assays.
-
Brooklyn, New York
- +2 more
Nov 1, 2022
Colorectal Cancer Trial in Guangzhou (Detection of ctDNA methylation)
Recruiting
- Colorectal Cancer
- Detection of ctDNA methylation
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Sep 25, 2022
Clot Analysis in Stroke Patients
Recruiting
- Stroke, Acute
- +2 more
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli, IRCCS
Feb 27, 2023
TINO: T Cells in the Nose of Older Adults
Recruiting
- Respiratory Tract Infections
- Aging
-
Leiden, Zuid Holland, NetherlandsLeiden University Medical Center
Sep 8, 2023
Hemostatic Profiles in Pediatric CKD
Active, not recruiting
- Kidney Disease, Chronic
- +3 more
- phlebotomy
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta - Egleston
Jul 19, 2022
Leiomyosarcoma Trial in Bad Saarow, Berlin (Dinutuximab Beta, Zoledronic acid, Interleukin-2)
Recruiting
- Leiomyosarcoma
- Dinutuximab Beta, Zoledronic acid, Interleukin-2
-
Bad Saarow, Germany
- +1 more
Jun 2, 2022
MDS, Del(5Q), Anemia Trial in Italy (Luspatercept Injection [Reblozyl])
Recruiting
- Myelodysplastic Syndromes
- +3 more
- Luspatercept Injection [Reblozyl]
-
Alessandria, Italy
- +22 more
Jun 20, 2023
Antiphospholipid Syndrome, COVID-19 Infection, COVID-19 Vaccination Trial in Frankfurt am Main
Recruiting
- Antiphospholipid Syndrome
- +2 more
-
Frankfurt am Main, GermanyCardioangiology Center Bethanien (CCB)
Apr 6, 2022
Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem
Not yet recruiting
- Hematologic Malignancy
- +5 more
- autologous hematopoietic stem cells added to planned CAR T
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
May 31, 2023
Patient Blood Management in Cardiac Surgery in Turkiye
Recruiting
- Coronary Artery Disease
- Iron Deficiency Anemia
-
Ankara, TurkeyAnkara University School of Medicine Heart Center
Oct 10, 2023
Massive Transfusion Trial
Not yet recruiting
- Massive Transfusion
- (no location specified)
Aug 28, 2023